Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases

US11096931B2 · kind B2 · utility

Assignee

• Janssen Sciences Ireland Unlimited Company · IE

Inventors

• Stefaan Julien Last · Lint, BE
• Bart Rudolf Romanie Kesteleyn · Berlare, BE
• Sandrine Céline GROSSE · Turnhout, BE
• Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
• Jan Martin Berke · Düsseldorf, DE
• Geerwin Yvonne Paul Haché · Brasschaat, BE
• Edgar Jacoby · Beerse, BE
• Carolina Martinez Lamenca · Beerse, BE
• Morgan Charles R. LECOMTE · Evere, BE
• Abdellah Tahri · Anderlecht, BE
• Sarah SAUVILLER · Geel, BE
• Karen Maria Vergauwen · Edegem, BE

Key dates

• Filing date: Feb 21, 2020
• Grant date: Aug 24, 2021
• Expiry date: Feb 21, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D409/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The application relates to amide derivatives, processes for their preparation, pharmaceutical compositions, and their uses, more particularly their uses in treating chronic hepatitis B virus (HBV) infection.